IndraLab

Statements

Roflumilast activates CYLD. 1 / 1

| 1

reach

"In addition to Rolipram, Roflumilast, the clinically approved PDE4 specific inhibitor, also significantly enhanced NTHi induced upregulation of CYLD (XREF_FIG)."

23575688

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Roflumilast activates CYLD. 1 / 1

INDRA sources:

Databases

Reading